STAT+: After death in gene therapy trial for a brain disease, progress is reported

An unexpected patient death rattled researchers who sought to pierce the blood-brain barrier. Now some think they have a better way of mitigating risks.
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk
Just in

Flavored nicotine tablets, the tobacco industry’s latest product, worry public health advocates
Just in

Opinion: The problem with ‘zero tolerance for bad behavior’ signs at hospitals
Just in

WHO warns progress on antimicrobial resistance falls short of 2030 targets

'I spent more than two days waiting in A&E' - NHS bids to end corridor care
